An expert panel has proposed a new framework for the diagnosis and treatment of multiple sclerosis to replace the current subtype classifications, based on disease progression.
Investegate announcements from Heidelberg Pharma AG, Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate
Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate13-Jul-2022 / 09:58 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014,.
Form 10-Q Pyxis Oncology, Inc For: Mar 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.